BIOCRYST PHARMACEUTICALS, INC.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2011
Total Assets: $82.2M
Liabilities Breakdown FY2011
Total Liabilities: $67.4M
Asset Breakdown
Total Assets: $82.2M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $16.4M | 20.0% |
| Accounts Receivable | $5.8M | 7.1% |
| Inventory | $263.0K | 0.3% |
| Property, Plant & Equipment | $1.1M | 1.3% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $58.6M | 71.2% |
Liabilities Breakdown
Total Liabilities: $67.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.5M | 3.7% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $64.9M | 96.3% |